Radiopharm Theranostics Limited (ASX:RAD)
Australia
· Delayed Price · Currency is AUD 0.0260
0.00 (0.00%)
Jun 13, 2025, 3:56 PM AEST
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of 60.68 million as of June 13, 2025. Its market cap has increased by 276.62% in one year.
Market Cap
60.68M
Enterprise Value
23.05M
Revenue
330.63K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
Market Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from 101.33M to 60.68M, a decrease of -40.12%. That is a compound annual growth rate of -13.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 13, 2025 | 60.68M | 15.27% |
| Dec 31, 2024 | 52.65M | 91.43% |
| Dec 29, 2023 | 27.50M | -20.28% |
| Dec 30, 2022 | 34.50M | -65.53% |
| Dec 31, 2021 | 100.07M | -1.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 115.66B |
| Pro Medicus | 28.26B |
| Cochlear | 17.84B |
| Sonic Healthcare | 12.91B |
| Ramsay Health Care | 8.52B |
| Telix Pharmaceuticals | 8.38B |
| Ansell | 4.45B |
| Mesoblast | 2.29B |